News & Analysis on Clinical Trial Services & Contract Research And Development
According to data presented this week, multiple second-generation antisense drugs that show potential as new treatments for asthma could represent the future in treating this disorder that has soared in worldwide cases, particularly amongst children.
Able Laboratories has announced sweeping job cuts across its manufacturing division in the wake of the quality control problems emerging at its plant in the US, reports Phil Taylor.
Chemical Abstracts Service and FIZ Karlsruhe have launched new software that is set to provide insights into trends and patterns in scientific and patent information, which is achievable through greater value from search results.
Marchesini has made its first foray into the market for stickpack packaging with the launch of a complete automated line aimed at manufacturers in the pharmaceutical, cosmetics and food industries, writes Phil Taylor.
An official of the Food and Drug Administration (FDA) has admitted that the regulatory agency was "the single greatest obstacle to doing anything effective" regarding Vioxx, adding that the FDA could have prevented the deaths resulting from the...
US researchers have identified an enzyme activity that is inactivated in all reported mutant forms of a disease protein, opening up opportunities for therapies to treat ataxia, a rare hereditary neurological disease that affects 1/100,000 people...
The European Union is to part-finance the creation of a European Theoretical Spectroscopy Facility (ETSF) to advance collaboration across the continent in the field of nanotechnology, reports Phil Taylor.
Targeted Genetics Corporation announced the issuance of a new patent, which covers the company's approach to increase carrying capacity of adeno-associated virus (AAV) technology platform expanding the potential applications of AAV-based gene delivery.
Ablynx has announced that it had signed a collaborative agreement with the National Research Council of Canada (NRC) Institute for Biological Sciences (IBS) that aims to concentrate its discovery efforts in the area of neurodegenerative diseases.
Canadian packaging technology company Creo has teamed up with XINK Laboratories, a company that makes conducting ink for printing radiofrequency identification (RFID) antennas, to address RFID tag security issues.